DVS Sciences to be Featured in Upcoming Episode of Innovations
Sunnyvale, CA (PRWEB) October 24, 2013 -- DVS Sciences Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research technology, announced today that they will be participating in an upcoming episode of Innovations, hosted by Ed Begley, Jr.
In this episode, Innovations will explore the transformative impact that the Mass Cytometry platform, pioneered by DVS, is having on scientific discovery. One of the major challenges facing researchers today is how best to untangle the function of biological systems given the functional heterogeneity of the many different cell types that make up the system.
“We are very excited about this opportunity to inform researchers and the public on the power of the CyTOF instrument and our Mass Cytometry technology,” stated Joe Victor, President and CEO of DVS Sciences.
Audiences will learn about mass cytometry, which includes the CyTOF 2 mass cytometer and associated metal-tagged reagents. In addition, viewers will be educated on how mass cytometry provides researchers with an unparalleled ability to phenotypically and functionally profile cells from normal and diseased states, and has been used in high-dimensional studies in diverse disciplines including immunology, cancer research, stem cell biology and drug profiling.
“DVS Sciences is committed to developing robust, innovative instrumentation that accelerate medical research and transform drug discovery," said Michele Nehls, producer for the series. "I'm really looking forward to providing this vital information to our audience."
About DVS Sciences, Inc.
DVS Sciences, Inc. manufactures and globally distributes novel bioanalytical solutions for use in biomarker discovery, biological research and potential future use in clinical applications. The patented multi-parameter technology comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF, and the MaxPar suite of stable isotope-tagged panel kits and reagents. The CyTOF platform overcomes the limitations of conventional flow cytometry, simplifies sample preparation, and can simultaneously identify up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada, Europe and Asia.
DVS Sciences has its global headquarters and reagent kit manufacturing in Sunnyvale, California with a R&D and instrument manufacturing facility near Toronto, Canada and a sales/support office in the UK.
For more information on DVS Sciences, please contact Nicole Ellis-Ovadia at +1-408-900-7224 or visit http://www.dvssciences.com.
About Innovations:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.
For more information visit: http://www.innovationstelevision.com or call (866) 496-4065.
About DMG Productions:
The DMG production team consists of producers, cameramen and editors that have worked for CNN, TLC, Discovery, and other major news and cable networks. Our staff includes personnel specialized in various fields from agriculture to medicine, independent films to regional news. Our field producers utilize the core concepts from our producers who storyboard our programs, and work closely with experts in the field to develop the educational programs. This powerful force enables us to consistently produce commercial-free, educational programming that both viewers and networks depend on.
For more information, please contact Michele Nehls, Senior Producer for DMG Productions, LLC and the Innovations series, at: (866) 496-4065 x 822 or michele(at)innovationstelevision(dot)com.
Michele Nehls, DMG Productions, http://www.dmgproductions.org, +1 866-496-4065 802, [email protected]
Share this article